Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisu Huang

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|January 2, 2023
Risk of malignancy following exposure to Epstein-Barr Virus associated infectious mononucleosis: A nationwide population-based cohort studyKang Cai, Baosong Zhou, Heyu Huang, et al.
BMC Infectious Diseases|November 7, 2025
Novel screening model for infectious mononucleosis in febrile pediatric patients using a 3D-DIFF scattergramZhaoyang Peng, Jingxian Zhang, Lin Chen, et al.
Infection and Drug Resistance|October 18, 2023
A Multicenter Epidemiological and Pathogenic Characteristics Study of Community-Acquired Bacterial Meningitis Children in China: Results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019-2020Caiyun Wang, Hongmei Xu, Gang Liu, et al.
Frontiers in Cellular and Infection Microbiology|April 1, 2024
A multicenter clinical epidemiology of pediatric pneumococcal meningitis in China: results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019-2020Caiyun Wang, Hongmei Xu, Gang Liu, et al.
Annals of Medicine|November 11, 2025
Incidence and risk factors of abnormal liver function and anti-tuberculosis drug-induced liver injury: a multicenter retrospective study involving 482 chinese pediatric tuberculosis patientsYiqing Zhou, Min Wang, Hongmei Xu, et al.
BMC Pediatrics|July 2, 2025
Paxlovid for the treatment of severe or critical COVID-19 in childrenLinjuan Xiang, Qun Wang, Yanwen Xu, et al.
BMC Infectious Diseases|December 26, 2025
Pediatric drug-sensitive tuberculosis treatment regimen profiles and treatment outcomes in mainland China, 2017-2022: a multi-center studyXinxin Zeng, Hao Xu, Aole Li, et al.
Journal of Infection and Public Health|November 13, 2025
The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world studyXinxin Zeng, Hao Yao, Aole Li, et al.
Infectious Diseases and Therapy|October 23, 2025
Baloxavir Marboxil in Chinese Pediatric Patients Aged 1 to < 5 Years with Influenza: Safety and Clinical and Virologic OutcomesYuchuan Li, Peng Guo, Chenguang Jia, et al.
Microbiology Spectrum|March 25, 2024
Prognostic value of poly-microorganisms detected by droplet digital PCR and pathogen load kinetics in sepsis patients: a multi-center prospective cohort studyYuanhan Zhao, Ke Lin, Haocheng Zhang, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|January 2, 2023
Risk of malignancy following exposure to Epstein-Barr Virus associated infectious mononucleosis: A nationwide population-based cohort studyKang Cai, Baosong Zhou, Heyu Huang, et al.
BMC Infectious Diseases|November 7, 2025
Novel screening model for infectious mononucleosis in febrile pediatric patients using a 3D-DIFF scattergramZhaoyang Peng, Jingxian Zhang, Lin Chen, et al.
Infection and Drug Resistance|October 18, 2023
A Multicenter Epidemiological and Pathogenic Characteristics Study of Community-Acquired Bacterial Meningitis Children in China: Results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019-2020Caiyun Wang, Hongmei Xu, Gang Liu, et al.
Frontiers in Cellular and Infection Microbiology|April 1, 2024
A multicenter clinical epidemiology of pediatric pneumococcal meningitis in China: results from the Chinese Pediatric Bacterial Meningitis Surveillance (CPBMS) 2019-2020Caiyun Wang, Hongmei Xu, Gang Liu, et al.
Annals of Medicine|November 11, 2025
Incidence and risk factors of abnormal liver function and anti-tuberculosis drug-induced liver injury: a multicenter retrospective study involving 482 chinese pediatric tuberculosis patientsYiqing Zhou, Min Wang, Hongmei Xu, et al.
BMC Pediatrics|July 2, 2025
Paxlovid for the treatment of severe or critical COVID-19 in childrenLinjuan Xiang, Qun Wang, Yanwen Xu, et al.
BMC Infectious Diseases|December 26, 2025
Pediatric drug-sensitive tuberculosis treatment regimen profiles and treatment outcomes in mainland China, 2017-2022: a multi-center studyXinxin Zeng, Hao Xu, Aole Li, et al.
Journal of Infection and Public Health|November 13, 2025
The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world studyXinxin Zeng, Hao Yao, Aole Li, et al.
Infectious Diseases and Therapy|October 23, 2025
Baloxavir Marboxil in Chinese Pediatric Patients Aged 1 to < 5 Years with Influenza: Safety and Clinical and Virologic OutcomesYuchuan Li, Peng Guo, Chenguang Jia, et al.
Microbiology Spectrum|March 25, 2024
Prognostic value of poly-microorganisms detected by droplet digital PCR and pathogen load kinetics in sepsis patients: a multi-center prospective cohort studyYuanhan Zhao, Ke Lin, Haocheng Zhang, et al.
Pageof 9